(Q34450198)

2 August 2017

A simple pharmacokinetic method for separating the three acetylation phenotypes: a preliminary report (English)

1 reference

2 August 2017

Lee EJ

1

1 reference

PubMed ID

7059437

2 August 2017

Lee LK

series ordinal

2

1 reference

PubMed ID

7059437

2 August 2017

language of work or name

English

0 references

publication date

1 March 1982

1 reference

British Journal of Clinical Pharmacology

2 August 2017

1 reference

2 August 2017

13

1 reference

2 August 2017

375-378

1 reference

2 August 2017

3

1 reference

Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype

2 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1402120

Acetylator phenotype and the antihypertensive response to hydralazine

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1402120

Acetylator phenotyping of tuberculosis patients using matrix isoniazid or sulphadimidine and its prognostic significance for treatment with several intermittent isoniazid-containing regimens

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1402120

Frequency of systemic lupus erythematosus in different ethnic groups in hawaii

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1402120

Disease and Acetylation Polymorphism

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1402120

Clinical consequences of polymorphic acetylation of basic drugs

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1402120

Isoniazid and Iproniazid: Activation of Metabolites to Toxic Intermediates in Man and Rat

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1402120

Kinetic discrimination of three sulfamethazine acetylation phenotypes

6 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1982.TB01388.X

Increased incidence of isoniazid hepatitis in rapid acetylators: possible relation to hydrazine metabolites

21 January 2018

1 reference

12 December 2020

Relationship of sulfamethazine disposition kinetics to acetylator phenotype in man. A preliminary study

1 reference

12 December 2020

Dose-dependent changes in sulfamethazine kinetics in rapid and slow isoniazid acetylators

1 reference

12 December 2020

Acetylator phenotype in patients with breast cancer

1 reference

12 December 2020

Genetic variation in N-acetylation of carcinogenic arylamines by human and rabbit liver

1 reference

12 December 2020

Screening methods using sulfamethazine for determining acetylator phenotype

1 reference

12 December 2020

Determination of the acetylator phenotype and pharmacokinetics of some sulphonamides in man

1 reference

12 December 2020

10.1111/J.1365-2125.1982.TB01388.X

Identifiers

DOI

1 reference

2 August 2017

1 reference

2 August 2017

1 reference

PubMed ID

7059437